Skip to content

Topic

Health Care

50 stories

Biogen

Biogen to Acquire Human Immunology Biosciences in $1.8 Bln Deal

Biotechnology Company Biogen, on Wednesday, announced an agreement to acquire Human Immunology Biosciences (HI-Bio) for $1.15 billion upfront and up to $650 million in potential milestone payments, boosting Biogen’s pipeline with targeted therapies for severe immune-mediated diseases. HI-Bio’s lead asset, Felzartamab, is a fully human anti-CD38 monoclonal antibody. Felzartamab depletes CD38+ cells, including plasma and […]

Dhivya Dharshini1 min read

Pfizer in discussion to acquire Seagen, the cancer drugmaker

The Wall Street Journal reported on Sunday, citing people familiar with the situation, that Pfizer Inc. is in preliminary discussions to acquire cancer drugmaker Seagen Inc. in what could be a multi-billion-dollar deal. The people stated there is no assurance that a deal will be reached because the negotiations are in their early stages. There […]

Vandana Srinivas1 min read